Articles

Title

Date Published

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients.

September 1, 2010

Changes in platelet count in uncomplicated and severe falciparum malaria.

September 1, 2010

Time interval from cigarette smoke exposure to blood donation and markers of inflammation: should a smoking cut-off be designated?

September 1, 2010

Significance of anti-HBc screening of blood donors & its association with occult hepatitis B virus infection: Implications for blood transfusion.

September 1, 2010

Detection of blood-transmissible agents: can screening be miniaturized?

September 1, 2010

Keeping transfusion blood safe.

September 1, 2010

Jehovah’s Witness patients. [Article in Japanese]

September 1, 2010

Blood banks, biobanks, and the ethics of donation.

September 1, 2010

Emergency department blood transfusion predicts early massive transfusion and early blood component requirement.

September 1, 2010

A solution to the problem of studying blood donor-related risk factors when patients have received multiple transfusions.

September 1, 2010

Preoperative evaluation, preparation and outcome prediction. II: preface and comments. [Article in Japanese]

September 1, 2010

Trends in blood collection and transfusion.

September 1, 2010

Blood transfusion practices at a level one trauma centre: a one-year retrospective review.

September 1, 2010

Effects of blood conservation on the incidence of anemia and transfusions in pediatric parapneumonic effusion: a hospitalist perspective.

September 1, 2010

Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.

September 1, 2010

Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility. [Article in Chinese]

September 1, 2010

Gynecologic surgery and the management of hemorrhage.

September 1, 2010

The morbidly adherent placenta: an overview of management options.

September 1, 2010

Polymerization of human hemoglobin using the crosslinker 1,11-bis(maleimido)triethylene glycol for use as an oxygen carrier.

September 1, 2010

Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.

September 1, 2010